Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Legend Biotech (LEGN) Cost of Revenue (2019 - 2025)

Historic Cost of Revenue for Legend Biotech (LEGN) over the last 7 years, with Q3 2025 value amounting to $52.6 million.

  • Legend Biotech's Cost of Revenue rose 1883.22% to $52.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $49.1 billion, marking a year-over-year increase of 4527.26%. This contributed to the annual value of $147.5 billion for FY2024, which is 5663.14% up from last year.
  • As of Q3 2025, Legend Biotech's Cost of Revenue stood at $52.6 million, which was up 1883.22% from $48.1 million recorded in Q2 2025.
  • In the past 5 years, Legend Biotech's Cost of Revenue ranged from a high of $48.9 billion in Q4 2024 and a low of $16.8 million during Q2 2021
  • In the last 5 years, Legend Biotech's Cost of Revenue had a median value of $27.4 million in 2022 and averaged $5.1 billion.
  • As far as peak fluctuations go, Legend Biotech's Cost of Revenue skyrocketed by 20489618.03% in 2021, and later crashed by 9984.12% in 2022.
  • Quarter analysis of 5 years shows Legend Biotech's Cost of Revenue stood at $52.8 million in 2021, then crashed by 51.1% to $25.8 million in 2022, then surged by 130314.75% to $33.7 billion in 2023, then soared by 45.28% to $48.9 billion in 2024, then crashed by 99.89% to $52.6 million in 2025.
  • Its last three reported values are $52.6 million in Q3 2025, $48.1 million for Q2 2025, and $41.0 million during Q1 2025.